Key facts
- A Missouri jury rejected claims against Mead Johnson.
- The lawsuit alleged Mead Johnson's preterm baby formula caused a dangerous bowel disease.
- The verdict sides with the Enfamil maker.
- The case was brought by an Illinois mother.
- This is the latest trial in nearly 1,000 similar lawsuits against Mead Johnson.
- The disease in question is necrotizing enterocolitis (NEC).
- NEC is a severe gastrointestinal condition affecting newborns.
- NEC primarily affects premature infants.
A jury in Missouri has delivered a verdict in favor of Mead Johnson, a prominent manufacturer of infant formula, in a lawsuit alleging that its specialized formula for preterm babies caused a dangerous bowel disease. The jury found no liability on the part of Mead Johnson, rejecting the claims brought by an Illinois mother. The lawsuit centered on allegations that the company's Enfamil formula, designed for premature infants, led to necrotizing enterocolitis (NEC), a severe gastrointestinal condition that can affect vulnerable newborns.
This verdict is the latest development in a series of nearly 1,000 lawsuits filed against Mead Johnson concerning its preterm infant formula. The case highlighted the ongoing legal challenges the company faces from families who believe their children suffered harm due to the specialized product. The outcome in Missouri provides a significant legal victory for Mead Johnson amidst these numerous claims.